Öz
Breast cancer is the most frequent cancer type in women. When we consider the increase in its the frequency and the decrease in age of diagnosed patients, we realise that the importance of a screening program and breast cancer awareness is increasing day by day in our country. The population of young women is significantly higher than that in Europan countries and the incidence of premenopausal breast cancer is dramatically high in Turkey. Raised canser awareness is essential for the effectiveness of a cancer screening program. One way to raise the awareness of breast cancer is through continuous education strategies. The main objective should be to develop a broad screening program that allows identification of high-risk patients in the communities. This program should be designed according to the specific conditions of the country rather than be based on a random screening
Anahtar Kelimeler
breast cancer awareness of breast cancer screening of breast cancer
Kaynakça
- Parkin DM, Bray F, Ferlay J, Pisani B. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
- T.C. Sağlık Bakanlığı sağlık istatistikleri yıllığı 2010.ss.27-8. http://sbu. saglik.gov.tr/Ekutuphane/kitaplar/saglikistatistikleriyilligi2010.pdf
- Ozmen V. Breast cancer in the World and Turkey, J Breast Health 2008;4:6-12.
- Fidaner C, Eser SY, Parkin DM. Incidence in Izmir in 1993-1994: first results from Izmir Cancer Registry. Eur J Cancer 2001;37:83-92.
- Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group. Effect of mamographhic screening from age 40 years on breast cancer mortality at 10 years follow-up: a randomised controlled trial. Lancet 2006;368:2053-60.
- Alexander FE, Anderson TJ, Browb HK, Forrest AP, Hepburn W, Kirkpatric AE, et al. 14 years of follow-up from Edinburg randomised trial of breast cancer screening. Lancet 1999;353:1903-8.
- Ulusal Kanser Kontrol Programı 2009-2015 (Yayın.no.760). Tuncer M (Editor). Ankara: T.C. Sağlık Bakanlığı, Kanserle Savaş Dairesi Başkanlığı, 2009.
- Meme Kanseri Tarama Programı Ulusal Standartları. kanser.gov.tr/ Dosya/tarama/meme.pdf
- Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, et al. Guideline implementation for breast healthcare in low and middle- income countries, early detection resource alocation. Cancer 2008;113:2244-56.
- Reynolds T. Declining breast cancer mortality: what’s behind it? J Natl Cancer Inst 1999;91:750 –3.
- Cancer Facts and Figures, American Cancer Society, 2014. http:// www.cancer.org/acs/groups/content/@research/documents/ webcontent/acspc-042151.pdf
- Secginli S, Nahcivan NO. Factors associated with breast cancer screening behaviors in a sample Turkish women: a questionnaire survey. Int J Nurs Stud 2006;43:161-71.
- Kılıç D, Sağlam R, Kara Ö. Üniversite öğrencilerinde meme kanseri farkındalığını etkileyen faktörlerin incelenmesi, J Breast Health, 2009;5;195-99.
- Singletary SE. Rating the risk factors for breast cancer. Ann Surg 2003;237:474-82.
- Gulluoglu BM. Risk factors. Essentials in the Management of Breast Diseases’da.Ed. Gazioğlu E. Bucharest, Celcius Medical Publishing 2005;131-45.
- Ravdin PM, Cronin KA, How lander N, Berg CD, Chelobowski RT, Feuer EJ, et al. The decrease in breast-cancer incidance in 2003 in the United States. N Eng J Med 2007;356:1670-4.
- Kayhan A, Arıbal E. Meme kanseri taraması: Neden yapıyoruz? Ne zaman? Değerlendirmede yaşanan sorunlar. Trd Sem 2014;2:230-40.
- Robson M, Offit K. Management of an inherited predisposition to breast cancer. N Eng J Med 2007;357:154-62.
- National Comprehensive Cancer Network Clinical Practice
- Guidelines in Oncolocy (NCCN Guidelines®), Breast Cancer Screening and Diagnosis, Version 1.2015. http://www.nccn.org/professionals/ physician_gls/pdf/breast-screening.pdf
- National Comprehensive Cancer Network Clinical Practice
- Guidelines in Oncolocy (NCCN Guidelines®), Genetic/Familial High Risk Assessment: Breast and Ovarian, Version 2.2015. http://www. nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
Öz
Meme kanseri kadın cinsiyette en sık görülen kanserdir. Ülkemizde meme kanseri görülme sıklığındaki artış ve görülme yaşındaki düşüş göz önüne alındığında meme kanseri farkındalığı ve tarama programlarının önemi gün geçtikçe daha da artmaktadır. Batı toplumlarına kıyasla ülkemizde genç kadın nüfusu belirgin biçimde fazla olup premenopozal meme kanseri insidansı da çarpıcı biçimde yüksektir. Etkin bir kanser tarama programı için toplumsal farkındalık şarttır. Devamlılık arz eden bir eğitim stratejisi ile bu farkındalığın sağlanması, toplumdaki yüksek riskli hastaların tespitine olanak veren, fırsatçı taramadan ziyade ülke koşullarına uygun şekillendirilmiş geniş tabanlı bir toplumsal tarama programı oluşturmak asıl hedef olmalıdır
Anahtar Kelimeler
Kaynakça
- Parkin DM, Bray F, Ferlay J, Pisani B. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
- T.C. Sağlık Bakanlığı sağlık istatistikleri yıllığı 2010.ss.27-8. http://sbu. saglik.gov.tr/Ekutuphane/kitaplar/saglikistatistikleriyilligi2010.pdf
- Ozmen V. Breast cancer in the World and Turkey, J Breast Health 2008;4:6-12.
- Fidaner C, Eser SY, Parkin DM. Incidence in Izmir in 1993-1994: first results from Izmir Cancer Registry. Eur J Cancer 2001;37:83-92.
- Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group. Effect of mamographhic screening from age 40 years on breast cancer mortality at 10 years follow-up: a randomised controlled trial. Lancet 2006;368:2053-60.
- Alexander FE, Anderson TJ, Browb HK, Forrest AP, Hepburn W, Kirkpatric AE, et al. 14 years of follow-up from Edinburg randomised trial of breast cancer screening. Lancet 1999;353:1903-8.
- Ulusal Kanser Kontrol Programı 2009-2015 (Yayın.no.760). Tuncer M (Editor). Ankara: T.C. Sağlık Bakanlığı, Kanserle Savaş Dairesi Başkanlığı, 2009.
- Meme Kanseri Tarama Programı Ulusal Standartları. kanser.gov.tr/ Dosya/tarama/meme.pdf
- Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, et al. Guideline implementation for breast healthcare in low and middle- income countries, early detection resource alocation. Cancer 2008;113:2244-56.
- Reynolds T. Declining breast cancer mortality: what’s behind it? J Natl Cancer Inst 1999;91:750 –3.
- Cancer Facts and Figures, American Cancer Society, 2014. http:// www.cancer.org/acs/groups/content/@research/documents/ webcontent/acspc-042151.pdf
- Secginli S, Nahcivan NO. Factors associated with breast cancer screening behaviors in a sample Turkish women: a questionnaire survey. Int J Nurs Stud 2006;43:161-71.
- Kılıç D, Sağlam R, Kara Ö. Üniversite öğrencilerinde meme kanseri farkındalığını etkileyen faktörlerin incelenmesi, J Breast Health, 2009;5;195-99.
- Singletary SE. Rating the risk factors for breast cancer. Ann Surg 2003;237:474-82.
- Gulluoglu BM. Risk factors. Essentials in the Management of Breast Diseases’da.Ed. Gazioğlu E. Bucharest, Celcius Medical Publishing 2005;131-45.
- Ravdin PM, Cronin KA, How lander N, Berg CD, Chelobowski RT, Feuer EJ, et al. The decrease in breast-cancer incidance in 2003 in the United States. N Eng J Med 2007;356:1670-4.
- Kayhan A, Arıbal E. Meme kanseri taraması: Neden yapıyoruz? Ne zaman? Değerlendirmede yaşanan sorunlar. Trd Sem 2014;2:230-40.
- Robson M, Offit K. Management of an inherited predisposition to breast cancer. N Eng J Med 2007;357:154-62.
- National Comprehensive Cancer Network Clinical Practice
- Guidelines in Oncolocy (NCCN Guidelines®), Breast Cancer Screening and Diagnosis, Version 1.2015. http://www.nccn.org/professionals/ physician_gls/pdf/breast-screening.pdf
- National Comprehensive Cancer Network Clinical Practice
- Guidelines in Oncolocy (NCCN Guidelines®), Genetic/Familial High Risk Assessment: Breast and Ovarian, Version 2.2015. http://www. nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Collection |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Aralık 2016 |
| Yayımlandığı Sayı | Yıl 2016Sayı: 4 |